Skip to main content
Clinical Trials/NCT05844722
NCT05844722
Completed
Not Applicable

Effectiveness of Mindfulness-based Cognitive Therapy Undergoing Post-stroke Rehabilitation: a Randomized Controlled Trial

National Institute for Medical Rehabilitation, Hungary1 site in 1 country93 target enrollmentFebruary 4, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
National Institute for Medical Rehabilitation, Hungary
Enrollment
93
Locations
1
Primary Endpoint
Change from 6 weeks on Beck Depression Inventory (BDI) at 3 months
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to investigate the efficacy of mindfulness-based cognitive therapy compared to usual care for stroke survivors undergoing inpatient rehabilitation.

Detailed Description

It was hypothesized that group-based MBCT would lead to improving mood, mindfulness, social support, physical, and neurocognitive function; and that these improvements would be maintained over the 3-month follow-up period. Participants in the control group received only usual care, the intervention group were involved in MBCT intervention in addition to usual care. MBCT intervention was designed to consist of eight 1.5-hour group sessions over 6 consecutive weeks.

Registry
clinicaltrials.gov
Start Date
February 4, 2019
End Date
September 27, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Institute for Medical Rehabilitation, Hungary
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • stroke patients with functional impairments
  • confirmation of stroke by CT or MRI scan
  • age between 18-90 years
  • had adequate communication skills, cognitive and physical capacity to participate in study activities
  • competence to provide informed consent

Exclusion Criteria

  • severe cognitive impairment according to the Word List Learning Instrument (total score \<7)
  • severe depression according to the Beck Depression Inventory (BDI) (total score\>25)
  • history of severe mental illness (psychotic disorder, schizophrenia, severe depression, bipolar disorder, PTSD, suicidal tendencies)
  • the current change in the antidepressant therapy.

Outcomes

Primary Outcomes

Change from 6 weeks on Beck Depression Inventory (BDI) at 3 months

Time Frame: 6 weeks and 3 months

Beck Depression Inventory (BDI) was used to assess severity of the depression with 21 items scored from 0 to 3 (hiv, Beck, 1961). Scores range from 0 to 63 with 0-9 representing normal value, 10-18 mild, 19-25 moderate, and ≥ 26 severe depression.

Change from baseline on Beck Depression Inventory (BDI) at 6 weeks

Time Frame: Baseline and 6 weeks

Beck Depression Inventory (BDI) was used to assess severity of the depression with 21 items scored from 0 to 3 (hiv, Beck, 1961). Scores range from 0 to 63 with 0-9 representing normal value, 10-18 mild, 19-25 moderate, and ≥ 26 severe depression.

Change from baseline on The Spielberger State-Trait Anxiety Inventory (STAI-X) at 6 weeks

Time Frame: Baseline and 6 weeks

The Spielberger State-Trait Anxiety Inventory (STAI-X) was used to assess anxiety both as a state and trait. State anxiety was measured by STAI form X-1, requiring participants to answer questions about how they feel right now. Trait anxiety was measured by the STAI form X-2, requiring participants to answer questions about how they feel generally. Both scales (X-1, X-2) consist of 20 items scored from 1 to 4. Scores range from 20 to 80 with higher scores representing higher state or trait anxiety.

Change from 6 weeks on The Spielberger State-Trait Anxiety Inventory (STAI-X) at 3 months

Time Frame: 6 weeks and 3 months

The Spielberger State-Trait Anxiety Inventory (STAI-X) was used to assess anxiety both as a state and trait. State anxiety was measured by STAI form X-1, requiring participants to answer questions about how they feel right now. Trait anxiety was measured by the STAI form X-2, requiring participants to answer questions about how they feel generally. Both scales (X-1, X-2) consist of 20 items scored from 1 to 4. Scores range from 20 to 80 with higher scores representing higher state or trait anxiety.

Secondary Outcomes

  • Change from baseline on The Five Facet Mindfulness Questionnaire (FFMQ) at 6 weeks(Baseline and 6 weeks)
  • Change from 6 weeks on The Five Facet Mindfulness Questionnaire (FFMQ) at 3 months(6 weeks and 3 months)
  • Change from baseline on The Multidimensional Scale of Perceived Social Support Scale(MSPSS) at 6 weeks(Baseline and 6 weeks)
  • Change from 6 weeks on The Multidimensional Scale of Perceived Social Support Scale (MSPSS) at 3 months(6 weeks and 3 months)
  • Change from baseline on Touluose-Piéron test(TP) at 6 weeks(Baseline and 6 weeks)
  • Change from 6 weeks on Touluose-Piéron test(TP) at 3 months(6 weeks and 3 months)
  • Change from 6 weeks on Fugl-Meyer Assessment (FMA) at 3 months(6 weeks and 3 months)
  • Change from 6 weeks on Functional Independence Measure (FIM) at 3 months(6 weeks and 3 months)
  • Change from baseline on Fugl-Meyer Assessment (FMA) at 6 weeks(Baseline and 6 weeks)
  • Change from baseline on Functional Independence Measure (FIM) at 6 weeks(Baseline and 6 weeks)

Study Sites (1)

Loading locations...

Similar Trials